LINC01094: A Drug Target / Disease Biomarker (G100505702)

Target Name: LINC01094

NCBI ID: G100505702

LINC01094

Other Name(s): long intergenic non-protein coding RNA 1094 | CTEPHA1 | Long intergenic non-protein coding RNA 1094, transcript variant 1

LINC01094: A Drug Target / Disease Biomarker

LINC01094 is a protein that is expressed in various tissues of the body, including the brain, heart, kidneys, and intestines. It is a member of the LINC (long non-coding RNA) family of proteins, which have been identified as potential drug targets or biomarkers.

LINC01094 is characterized by its unique structure and biology. It is a transmembrane protein that consists of an extracellular region, a transmembrane region, and an intracellular region. The extracellular region is involved in the protein's ability to interact with various cell signaling pathways, while the transmembrane region is responsible for the protein's localization and stability. The intracellular region interacts with various cellular components, including the nucleus, to regulate the expression and function of the protein.

LINC01094 is involved in a wide range of physiological processes in the body, including cell signaling, inflammation, and metabolism. It has been shown to play a role in various diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases.

One of the most promising aspects of LINC01094 is its potential as a drug target. LINC01094 has been shown to interact with a variety of small molecules, including pharmaceuticals, toxins, and natural compounds. This makes it a promising target for drug development in a variety of therapeutic areas, including neurological and cardiovascular diseases.

In addition to its potential as a drug target, LINC01094 has also been shown to be a valuable biomarker for a variety of diseases. Its expression has been associated with a range of diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases. This makes it a promising tool for the development of diagnostic tests and biomarkers for these diseases.

Overall, LINC01094 is a fascinating protein that has the potential to be a drug target or biomarker. Its unique structure and biology, as well as its involvement in a wide range of physiological processes, make it an attractive target for research and development in a variety of therapeutic areas.

Protein Name: Long Intergenic Non-protein Coding RNA 1094

The "LINC01094 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC01094 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets